Search+Investment IdeasDivi’s Laboratories stock saw momentum after a consolidation breakout on a weekly scale after 53 weeks which opened room for the stock to head higher.SynopsisDivi's Laboratories stock reached a new record high in July 2026. Chart patterns indicate continued upward momentum for the pharma stock. Short-term traders can consider buying the stock for a target of 8,000 levels. The stock has shown significant gains over recent weeks and months. Experts recommend buying with a stop loss below 6950 levels.Divi’s Laboratories Ltd, part of the pharma industry, hit a fresh record high in July 2026 and chart patterns suggest that the momentum is likely to continue.Short-term traders can look to buy the stock for a target of 8,000 levels in the next few weeks, suggest experts.The pharma stock picked up momentum after it gave a consolidation breakout on a weekly scale after fifty-three weeks which opened room for the stock to head higher.It has rallied BYETMarkets.com 3 mins readJul 21, 2026, 05:00:00 AM ISTGift this Story to your friendsFONT SIZEAbcSmallAbcMediumAbcLargeSAVEPRINTCOMMENTContinue reading with one of these options:Limited AccessFreeLogin to get access to some exclusive stories & personalised newslettersLogin NowUnlimited AccessStarting @ Rs120/monthGet access to exclusive stories, expert opinions & in-depth stock reportsSubscribe NowETUh-oh! This is an exclusive story available for selected readers only.Worry not. You’re just a step away.What’s Included withETPrime Membership